JP Morgan Chase’s Athenahealth, Inc. ATHN Stock Holding History

JP Morgan Chase’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-23,100	Closed	-$3.05M	–	6239
2018 Q4	$3.05M	Sell	23,100 -36,900	-62%	-$4.73M	﹤0.01%	2961
2018 Q3	$8.02M	Sell	60,000 -52,500	-47%	-$7.87M	﹤0.01%	2384
2018 Q2	$17.9M	Buy	+112,500	New	+$16.7M	﹤0.01%	1686
2018 Q1	–	Sell	-45,000	Closed	-$5.99M	–	5759
2017 Q4	$5.99M	Hold	45,000	–	–	﹤0.01%	2537
2017 Q3	$5.57M	Hold	45,000	–	–	﹤0.01%	2491
2017 Q2	$6.33M	Hold	45,000	–	–	﹤0.01%	2316
2017 Q1	$5.07M	Buy	45,000 +41,200	+1,084%	+$4.8M	﹤0.01%	2415
2016 Q4	$400K	Buy	+3,800	New	+$408K	﹤0.01%	3881

JP Morgan Chase's ATHN Position: Q1 2019 in Review

JP Morgan Chase sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 251,393 shares — an estimated $33.2M sold.

JP Morgan Chase first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $85.7M in Q1 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

JP Morgan Chase reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
JP Morgan Chase sold 251,393 Athenahealth, Inc. shares in Q1 2019, an estimated $33.2M.
JP Morgan Chase first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
JP Morgan Chase's Athenahealth, Inc. position peaked at $85.7M in Q1 2014.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.